A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 52
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CE
Long Form : converting enzyme
No. Year Title Co-occurring Abbreviation
1993 Differential reactivity of cortical and juxtamedullary glomeruli to adenosine-1 and adenosine-2 receptor stimulation and angiotensin-converting enzyme inhibition. CHA, JM, NECA
1993 Mnemogenic effects of injecting RA-octil, a CE-inhibitor derivate, systemically or into the basal forebrain. SP
1992 Alterations in the water intake caused by central inhibition of angiotensin-converting enzyme in the rat. Ang I, i.c.v, s.c
1992 Effects of converting enzyme inhibitors and the calcium antagonist nifedipine alone and in combination on precontracted isolated rabbit aortic rings. ---
1991 Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reduction. ---
1991 From tissue angiotensin converting enzyme inhibition to antihypertensive effect. Ang II, RAS
1991 Tissue renin-angiotensin systems: fact or fiction? ACE, Ang II, RAS
1990 The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition. BP, CEIs, RAS
1989 Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats. BP
10  1989 Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Ang II
11  1989 Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall. Ang II, RAS
12  1989 Effects of converting-enzyme inhibitor on hemodynamic actions of ANP in renal hypertensive rats. ANP, CI, RAS, TPR
13  1989 Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288. BBB, CNS
14  1989 Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors. CSF
15  1989 Pharmacological interference with the cardiac renin-angiotensin system. BK
16  1988 Brain angiotensin: pathways and pharmacology. RAS
17  1988 Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts. Ang, BK, CK, CP, LDH
18  1988 [Ex vivo and in vitro effects of trandolapril on the efflux of 22Na from the caudal artery of the SHR rat. Inhibition of vascular angiotensin II production]. ICE
19  1988 [Pharmacologic modification of the converting enzyme--local and systemic effects on the heart and blood vessels]. RAS
20  1987 Biosynthesis of catecholamines and sympathetic outflow in spontaneously hypertensive rats (SHR) after chronic treatment with CE blocking agents. Ang I, Ang II, HPLC, NE, PS, SHR
21  1987 CE inhibition and natriuresis with ramipril in conscious SHR: different modes of action of loop and thiazide diuretics. BP, HCT, SHR
22  1987 Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications. ---
23  1987 Effects of infusing alpha-atrial natriuretic peptide in primary hypertension during converting enzyme inhibition. ANP, BP, EN, PRA
24  1987 Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts. Ang I, BK
25  1987 Tissue converting enzyme inhibition and cardiovascular effects of converting enzyme inhibitors. ---
26  1986 Analysis of influence of extra- and intrarenally formed angiotensin II on renal blood flow. Ang I, RBF
27  1986 Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. Ang II, SHRSP
28  1986 Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. Ang II, RAS
29  1986 Converting enzyme activity in sow oviducts at different stages of the sex cycle. Influence of inhibitors of prostaglandin synthesis and its possible role in the inotropic effects of bradykinin. BK
30  1986 Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. RAS
31  1986 [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)]. SHRSP
32  1985 Comparison of different drug interference with the renin-angiotensin system. ---
33  1985 Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Ang I, BK, CON, SNS
34  1985 Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. SHRSP
35  1985 Physical performance during sustained converting enzyme inhibition with Hoe 498 in conscious dogs. ---
36  1984 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. SHRSP
37  1984 Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). ---
38  1984 Chemistry of the inhibitors of the renin-angiotensin system. Ang I, RAS
39  1984 Interaction of rabbit liver cathepsin M and fructose 1,6-bisphosphatase converting enzyme with their endogenous inhibitors. ---
40  1984 Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. Ang I, SHRSP
41  1983 Endogenous inhibitors of lysosomal proteinases. ---
42  1983 Protracted effect of converting-enzyme inhibition on the rat's response to intraarterial bradykinin. BK
43  1982 Capoten-induced juxtaglomerular hyperplasia in rabbits. PRA
44  1982 Juxtaglomerular angiotensin II formation. AFE
45  1982 No effect of intrarenal converting enzyme inhibition on canine renal blood flow. ---
46  1982 The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat. Ang II, RAS
47  1982 The localization of converting enzyme in kidney vessels of the rat. ---
48  1981 Angiotensin I conversion by the microcirculation of the nonhuman primate. Ab-AII, AI, AII, CEI
49  1981 Captopril and the maintenance of blood pressure after sinoaortic denervation in the rabbit. ---
50  1981 Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril. CEA
51  1980 Components of the renin-angiotensin system in the cerebrospinal fluid of rats and dogs with special consideration of the origin and the fate of angiotensin II. Ang I, Ang II, BBB, CSF, DOCA, RAS
52  1976 Substrate binding properties of converting enzyme using a series of p-nitrophenylalanyl derivatives of angiotensin I. ---